STOCK TITAN

Usana Health Sciences (USNA) Stock News

USNA NYSE

Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.

USANA Health Sciences, Inc. develops and manufactures nutritional supplements, functional foods, personal care and skincare products sold directly to Brand Partners and Preferred Customers across 25 global markets. Company news regularly centers on earnings releases, management commentary, omnichannel strategy, product innovation and channel expansion.

Recurring updates also cover product launches and quality validation for brands such as CellSentials, Celavive and Glow, along with the company’s controlling stake in Hiya Health Products, its ownership of Rise Wellness, athlete sponsorships and USANA Foundation activity.

Rhea-AI Summary

USANA has secured naming rights to the U.S. Ski & Snowboard's Center of Excellence, enhancing its commitment to elite athlete support through nutritional products. The partnership, ongoing since 2011, includes conducting two to three annual clinical studies to assess the effects of USANA's supplements on athlete performance. This collaboration aims to improve athletes' metrics, immune function during travel, and sleep quality. USANA aims to foster innovation in product development while supporting Olympic athletes' training and success.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.89%
Tags
none
-
Rhea-AI Summary

USANA Malaysia has been recognized as the No. 1 Combination Dietary Supplements Brand in Malaysia for the second consecutive year, according to Euromonitor International. This accolade reflects USANA's strong retail value share among supplement brands in the region. David Mulham, Chief Sales Officer, attributed this success to the commitment to science-based products that empower Associates to grow in Malaysia. Vivienne Lee, Vice President, highlighted the remarkable growth of USANA Malaysia since its establishment 13 years ago. This recognition underscores the brand's significant impact in the Malaysian market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.22%
Tags
none
-
Rhea-AI Summary

USANA Health Sciences reported a significant 14.5% increase in net sales for Q3 2020, totaling $298.5 million, driven by high product demand and effective incentive programs. Diluted EPS reached a record $1.44, up by 32.1% year-over-year. Active customers grew to 650,000, reflecting a 16.5% increase. The company raised its full-year 2020 net sales and EPS outlook to $1.090 - $1.115 billion and $5.15 - $5.45, respectively. USANA ended the quarter with $278.4 million in cash and no debt, highlighting a strong financial position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.96%
Tags
none
Rhea-AI Summary

USANA Health Sciences, Inc. (NYSE:USNA) announces the upcoming release of its third-quarter results on October 20, 2020, after market close. Following the earnings release, a "Management Commentary, Results and Outlook" will be available on the Company’s investor relations website. Additionally, a conference call with analysts and institutional investors is set for October 21, 2020, at 11:00 a.m. Eastern Time, which will be accessible via the internet.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.41%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.74%
Tags
none
-
Rhea-AI Summary

USANA Philippines has been recognized for the second consecutive year as the No. 1 Vitamins and Dietary Supplements Brand in the Philippines, according to Euromonitor International. This title reflects USANA’s strong retail value share in the country’s supplement market based on 2020 data. David Mulham, USANA's chief sales officer, and Aurora “Duday” Gaston, VP for the Philippines, emphasize the importance of this achievement and credit their team’s efforts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
none
-
Rhea-AI Summary

USANA has been recognized for the 13th consecutive year on Utah Business Magazine's Fast 50 list, ranking 35th in 2020. The accolade is based on revenue growth and overall revenue, validated by Tanner LLC. In 2019, USANA achieved net sales of $1.061 billion, marking its fourth consecutive billion-dollar year. Jim Brown, USANA's president, attributed this success to its independent sales force, dedicated employees, and innovative health products. The Fast 50 list highlights companies that show consistent financial growth and rapid expansion in Utah.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.99%
Tags
none
-
Rhea-AI Summary

On August 17, 2020, USANA announced the launch of its new Mood and Relaxation product line during a virtual convention. This includes the Stress Relief supplement and Calm Response essential oil balm, designed to enhance emotional and mental well-being. The herbal-based Stress Relief features ingredients like saffron and ashwagandha, while Calm Response contains a blend of calming essential oils. These products aim to address stress and promote positive emotional health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.79%
Tags
none

FAQ

What is the current stock price of Usana Health Sciences (USNA)?

The current stock price of Usana Health Sciences (USNA) is $22.03 as of July 13, 2026.

What is the market cap of Usana Health Sciences (USNA)?

The market cap of Usana Health Sciences (USNA) is approximately 405.8M.